JC

James Francis Callahan

SL Smithkline Beecham Limited: 28 patents #28 of 1,624Top 2%
GL Glaxo Group Limited: 8 patents #110 of 1,368Top 9%
SB Smithkline Beckman: 8 patents #14 of 166Top 9%
NP Nps Pharmaceuticals: 7 patents #14 of 103Top 15%
AL Astex Therapeutics Limited: 5 patents #50 of 199Top 30%
GL Glaxosmithkline: 5 patents #55 of 646Top 9%
NG Nycomed Austria Gmbh: 2 patents #7 of 15Top 50%
SP Smithkline Beeacham P.L.C.: 2 patents #217 of 690Top 35%
SB Smithkline Beechan: 1 patents #1 of 38Top 3%
📍 King of Prussia, PA: #5 of 578 inventorsTop 1%
🗺 Pennsylvania: #464 of 74,527 inventorsTop 1%
Overall (All Time): #39,326 of 4,157,543Top 1%
60
Patents All Time

Issued Patents All Time

Showing 1–25 of 60 patents

Patent #TitleCo-InventorsDate
11117905 Bisaryl heterocycles as NRF2 activators Roderick S. Davis, Nicole Cathleen Goodwin, Jeffrey K. Kerns 2021-09-14
11078216 Bisaryl amides as NRF2 activators Vincent J. Colandrea, Anthony William James Cooper, Nicole Cathleen Goodwin, Chelsea Ariane Huff, Joel David KARPIAK +2 more 2021-08-03
10604509 Nrf2 regulators Jeffrey K. Kerns, Thomas Daniel Heightman, Alison Jo-Anne Woolford, Ami Lakdawala Shah, Roderick S. Davis +3 more 2020-03-31
10485806 Nrf2 regulators Jeffrey K. Kerns, Hongxing Yan, Thomas Daniel Heightman, Jeffrey C. Boehm, Alison Jo-Anne Woolford 2019-11-26
10364256 Biaryl pyrazoles as NRF2 regulators Jeffrey K. Kerns, Peng Li, Tindy Li, Brent W. McCleland, Hong Nie +9 more 2019-07-30
10351530 Arylcyclohexyl pyrazoles as NRF2 regulators Jeffrey K. Kerns, Tindy Li, Brent W. McCleland, Hong Nie, Joseph E. Pero +7 more 2019-07-16
10272095 NRF2 regulators Jeffrey K. Kerns, Hongxing Yan, Thomas Daniel Heightman, Jeffrey C. Boehm, Alison Jo-Anne Woolford 2019-04-30
9227914 Calcilytic compounds Robert Marquis, Linda N. Casillas, Joshi M. Ramanjulu 2016-01-05
8980950 Calcilytic compounds Robert Marquis, Linda N. Casillas, Joshi M. Ramanjulu 2015-03-17
8586631 Calcilytic compounds Robert Marquis, Linda N. Casillas, Joshi M. Ramanjulu 2013-11-19
8399517 Calcilytic compounds Robert Marquis, Linda N. Casillas, Joshi M. Ramanjulu 2013-03-19
8354416 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase Jeffrey C. Boehm, Anthony William James Cooper, Stefano Livia, Paul Bamborough, Neysa Nevins +3 more 2013-01-15
8207176 Compounds Jeffrey C. Boehm, Anthony William James Cooper, Stefano Livia, Paul Bamborough, Neysa Nevins +3 more 2012-06-26
8084449 Dual pharmacophores—PDE4-muscarinic antagonistics Guoliang Lin, Zehong Wan, Hongxing Yan 2011-12-27
8071588 Dual pharmacophores—PDE4-muscarinic antagonistics Guoliang Lin, Zehong Wan, Hongxing Yan 2011-12-06
8067408 Dual pharmacophores—PDE4-muscarinic antagonistics Guoliang Lin, Zehong Wan, Hongxing Yan 2011-11-29
7829594 Calcilytic compounds Robert Marquis, Linda N. Casillas, Joshi M. Ramanjulu 2010-11-09
7678801 Compounds Jeffrey C. Boehm, Anthony William James Cooper, Stefano Livia, Neysa Nevins, Zehong Wan +3 more 2010-03-16
7674789 Compounds Zehong Wan, Hongxing Yan, Xichen Lin 2010-03-09
7629350 Compounds Jeffrey C. Boehm, Katherine L. Widdowson, Zehong Wan 2009-12-08
7550480 Compounds Jeffrey C. Boehm, Ralph F. Hall, Xichen Lin, Katherine L. Widdowson 2009-06-23
7514473 Calcilytic compounds Robert Marquis, Linda N. Casillas, Joshi M. Ramanjulu 2009-04-07
7482455 Chemical compounds Joelle Lorraine Burgess, Toshihiro Hamajima, Satoru Ida, Ichiro Mori, Jun Tang 2009-01-27
7479558 Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives Jeffrey C. Boehm, Zehong Wan, Hongxing Yan, Xichen Lin 2009-01-20
7375131 NF-κB inhibitors Yue Li 2008-05-20